Diffusion Pharmaceuticals LLC

Website Links

Description

Diffusion Pharmaceuticals LLC is a drug discovery and development company commercializing a revolutionary advancement in the treatment of oxygen deficiency at the cellular level. Our proprietary lead drug candidate, trans sodium crocetinate (TSC), is targeted at the destructive nature of cellular oxygen deficiency (known by the medical term “hypoxia”) found in indications such as peripheral vascular and arterial disease, hemorrhage, stroke, heart attack, congestive heart failure, respiratory disorders, treatment-resistant cancerous tumors and other conditions.

Products & services

Similar companies nearby